China NMPA Product Recall - Knee components

Bangmei (Shanghai) Trading Co., Ltd. initiated a Level II voluntary recall of specific knee joint components manufactured by Biomet Orthopedics, reported to the National Medical Products Administration (NMPA) on January 7, 2017. The recall, published on March 1, 2017, addressed critical labeling inaccuracies on product packaging. The issue originated from inadequate supplier clearance procedures at Biomet Orthopedics between April 5, 2016, and September 1, 2016. This procedural lapse resulted in certain batches of Vanguard PS open-box femoral condyle prostheses being potentially mislabeled with incorrect sizes or designated for the wrong side (right/left). Although the labeling errors were easily identifiable with an estimated incidence rate of 0.001%, and no adverse events or related complaints were reported in China, the company proceeded with the recall to uphold product safety and quality standards. Operating under the regulatory framework of the Medical Device Recall Event Report Form CFDA (Imported) No. 2014, the required action involved recalling all affected unused products, which have been successfully returned to the manufacturer, Biomet Orthopedics, as part of a global recall.